Clinical trial to treat rectal cancer spares major surgery
A new treatment for earlier-stage rectal cancer could transform how patients are treated for the disease, according to a landmark clinical trial.
Aug 24, 2026
0
6
MeSH tree: E02.186
A new treatment for earlier-stage rectal cancer could transform how patients are treated for the disease, according to a landmark clinical trial.
Aug 24, 2026
0
6
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of radiation therapy to treat adult patients with pancreatic cancer.
Aug 13, 2026
0
4
The first results from the multicenter FUSOMAP project, published in ESMO Open and led by VHIO's Molecular Oncology Group, show that the presence of intratumoral Fusobacterium in surgical tumor samples identifies a clinically ...
Aug 4, 2026
0
3
Artificial intelligence developed by researchers at UCL has revealed a promising combination of cancer treatments that could help patients with locally advanced rectal cancer live longer.
Jul 27, 2026
0
6
Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue ...
Jul 21, 2026
0
6
A research team led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan University, in collaboration with the Korea Institute of Science and Technology (KIST) and Incheon National University, ...
Jul 10, 2026
0
13
A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal ...
Jul 6, 2026
0
5
Cancer survivors significantly improved their strength and immune health after completing a 10-week resistance training program as part of a pilot study led by Shernan Holtan, MD, Chief of Blood and Marrow Transplantation ...
Jun 8, 2026
0
8
An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as non-muscle-invasive bladder cancer, is now being repurposed to address one of the biggest public health ...
Research led by a Keele University oncologist has found that a one-week course of post-surgery radiotherapy is just as safe and effective as the traditional three-week course for people with early-stage breast cancer. The ...
May 21, 2026
0
15